First Trust NYSE Arca Biotechnology Index Fund
242 hedge funds and large institutions have $645M invested in First Trust NYSE Arca Biotechnology Index Fund in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 91 reducing their positions, and 27 closing their positions.
4,845% more call options, than puts
Call options by funds: $1.43M | Put options by funds: $29K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
4.07% more ownership
Funds ownership: 49.65% → 53.72% (+4.1%)
3% less funds holding
Funds holding: 249 → 242 (-7)
9% less capital invested
Capital invested by funds: $707M → $645M (-$62.1M)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
40% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 91
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SOS
Silver Oak Securities
Jackson,
Tennessee
|
+$65.4M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$2.82M |
| 3 |
GVAG
Great Valley Advisor Group
Wilmington,
Delaware
|
+$2.63M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.13M |
| 5 |
AI
Atria Investments
Charlotte,
North Carolina
|
+$1.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$30.3M |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$11.1M |
| 3 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$5.59M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$5.44M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$2.46M |
FBT Hedge Fund Activity: Q3 2023 in Review
242 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2023, worth a combined $645M — down 8.8% from $707M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of FBT and 22 opened new positions — a net loss of 5 holders — while 91 trimmed existing stakes and 55 added.
The largest buyer was Silver Oak Securities, opening a new position worth an estimated $65.4M. The largest seller was Morgan Stanley, cutting an estimated $30.3M.
- 242 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2023, down from 249 in Q2 2023.
- Funds reported $645M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2023, down 8.8% quarter-over-quarter.
- 22 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2023 and 27 closed out, a net change of -5 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2023 was Silver Oak Securities, an estimated $65.4M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2023 was Morgan Stanley, an estimated $30.3M sold.
Based on aggregated 13F filings for Q3 2023.